PMA device
Urolume Endourethral Prosthesis for Prostatic Obstruction Secondary to Benign Prostatic Hypertrophy
Boston Scientific Corp · Stent, Urethral, Bulbous, Permanent Or Semi-Permanent (MES, Class III) · First FDA decision Jul 22, 2004, newest Jul 22, 2004Enlarged prostate (BPH)
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "Urolume Endourethral"
MAUDE reports
0
Brand "Urolume Endourethral", since 2015
PubMed studies
6
Mentioning "Urolume Endourethral"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Urolume Endourethral Prosthesis for Prostatic Obstruction Secondary to Benign Prostatic Hypertrophy
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- UROLUME ENDOURETHRAL PROSTHESIS FOR PROSTATIC OBSTRUCTION SECONDARY TO BENIGN PROSTATIC HYPERTROPHYPMA supplement
P920023-S015 · Decided Jul 22, 2004 · 752 days after receipt · Normal 180 Day Track
Device type: STENT, URETHRAL, BULBOUS, PERMANENT OR SEMI-PERMANENT (MES) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Urolume Endourethral", any status and sponsor, newest update first.
No registered device study names "Urolume Endourethral".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Urolume Endourethral", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MES
3 reports: 1 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Urolume Endourethral"[tiab]. The summary above synthesizes these.
- Urolume endourethral prosthesis for the treatment of urethral stricture disease: long-term results of the North American Multicenter UroLume Trial.
Badlani GH, Press SM, Defalco A, et al. · Urology · 1995Clinical Trial, Comparative Study
- Use of multiple urolume endourethral prostheses in complex bulbar urethral strictures.
Tillem SM, Press SM, Badlani GH · J Urol · 1997Clinical Trial, Multicenter Study
- Self-expanding stent insertion for urethral strictures: a 10-year follow-up.
De Vocht TF, van Venrooij GE, Boon TA · BJU Int · 2003
- A technique for removal of the Urolume endourethral wallstent prosthesis.
Anjum MI, Palmer JH · Br J Urol · 1995
- Percutaneous transvesical (antegrade) insertion of a Urolume endourethral prosthesis.
Anjum MI, Palmer JH · Br J Urol · 1996
- Prostatic stents. Current perspectives for the management of benign prostatic hyperplasia.
Kletscher BA, Oesterling JE · Urol Clin North Am · 1995Review
Other devices of this type
Also filed under product code MES.
- Urolume(R) EndoprosthesisBoston Scientific Corp · PMA 2001
- Ams Urolume EndoprosthesisBoston Scientific Corp · PMA 2011
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.